Varicella zoster virus vaccine live - sanofi pasteur

Drug Profile

Varicella zoster virus vaccine live - sanofi pasteur

Alternative Names: Chickenpox vaccine - sanofi pasteur

Latest Information Update: 24 Jan 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Osaka University
  • Class Varicella vaccines; Viruses
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Market Withdrawal Varicella zoster virus infections

Most Recent Events

  • 23 Jan 2014 Withdrawn for Varicella zoster virus infections in France (Injection) prior to January 2014
  • 19 Jan 2005 Aventis Pasteur is now called sanofi pasteur
  • 27 Aug 2004 Aventis has merged with Sanofi-Synthélabo to form Sanofi-Aventis
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top